QR-Code

Current insights into monitoring of congenital adrenal hyperplasia

The management of 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, remains challenging as both over- and undertreatment with hormone replacement therapy are associated with short and long-term complications. Monitoring of treatment efficacy typically combine...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Quinty M. Leusink, Elke E. W. Verploegen, Bas P. H. Adriaansen, Xinyi Chin, Nike M. M. L. Stikkelbroeck, Paul N. Span, Fred C. G. J. Sweep, Margo Dona, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2026-02-01
Schriftenreihe:Frontiers in Endocrinology
Schlagworte:
congenital adrenal hyperplasia (CAH)
21-hydroxylase deficiency (21OHD)
monitoring
biomarkers
reference intervals
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fendo.2026.1774145/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge